Episode 49
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
The Evidence Based Rheumatology Podcast
October 3, 20199m 40s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.